scholarly journals Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis

2018 ◽  
Vol 19 (1) ◽  
Author(s):  
Marlene Bloechliger ◽  
Daphne Reinau ◽  
Julia Spoendlin ◽  
Shih-Chen Chang ◽  
Klaus Kuhlbusch ◽  
...  
2009 ◽  
Vol 129 (11) ◽  
pp. 2604-2612 ◽  
Author(s):  
Yolanda B. Brauchli ◽  
Susan S. Jick ◽  
Montserrat Miret ◽  
Christoph R. Meier

2017 ◽  
Vol 22 (2) ◽  
pp. 74-82 ◽  
Author(s):  
Saskia G. Bruderer ◽  
Daniel Bodmer ◽  
Nadja A. Stohler ◽  
Susan S. Jick ◽  
Christoph R. Meier

Background and Objective: Ménière's disease (MD) is a disorder of the inner ear typically showing recurrent acute episodes of vertigo, hearing loss, and tinnitus. Epidemiologic studies on MD are scarce. We assessed the incidence rates (IRs) of MD and describe the characteristics of MD cases, comparing them to control patients without recorded evidence of MD. Study Design: We conducted a retrospective population-based follow-up study and a nested case-control analysis using data from the UK-based Clinical Practice Research Datalink. Methods: We identified patients between 18 and 79 years of age with an incident MD diagnosis between January 1993 and December 2014. We assessed the IRs of betahistine-treated MD. In the nested case-control analysis, we matched 4 controls to each MD case on sex, age, general practice, years of active history in the database, and calendar time. We conducted a χ2 test to present p values in order to compare the prevalence of demographics, comorbidities, and co-medication between cases and controls. Results: We identified 5,508 MD cases and 22,032 MD-free controls (65.4% females). The overall IR for MD in the UK was 13.1 per 100,000 person-years. More cases were female, and the mean age at diagnosis was 55.4 ± 13.7 years. Smoking and alcohol consumption were less prevalent among MD cases. Depression, other affective disorders, sleeping disorders, anxiety, and migraine were more prevalent among MD cases than among controls. Conclusions: MD is uncommon in primary care in the UK with a preponderance among females.


2018 ◽  
Vol 14 (11) ◽  
pp. e644-e652 ◽  
Author(s):  
Tina W.F. Yen ◽  
Ann B. Nattinger ◽  
Emily L. McGinley ◽  
Nicole Fergestrom ◽  
Liliana E. Pezzin ◽  
...  

Purpose: The effect of advanced practice provider (APP) involvement in oncology care on cancer-specific outcomes is unknown. We examined the association between team-based APP–physician care during chemotherapy and chemotherapy-related adverse events (AEs) among women with breast cancer. Methods: We performed separate nested case-control analyses in two national cohorts of women who received chemotherapy for incident breast cancer. Cohorts were identified from Medicare (≥ 65 years of age) and MarketScan (18 to 64 years of age) data. Cases experienced a chemotherapy-related AE (emergency room visit and/or hospitalization). Controls were matched 1:1 on the basis of each patient’s age, comorbidities, census region, state’s APP scope of practice regulations, and observation period from chemotherapy initiation to first AE. APP exposure (any outpatient claim billed by an APP during the observation period) was assessed for each matched pair member. Results: Among the 1,948 cases in the Medicare cohort, 225 (12%) had APP exposure before the first chemotherapy-related AE, compared with 213 controls (11%; P = .54). Among the 725 cases in the MarketScan cohort, 52 (7%) had APP exposure compared with 65 controls (9%; P = .21). In the matched case-control analysis, there was no association between outpatient APP exposure during chemotherapy and AEs in either cohort (Medicare: OR, 1.06 [95% CI, 0.87 to 1.30]; MarketScan: OR, 0.76 [95% CI, 0.50 to 1.14]). Conclusion: Our results suggest that team-based APP-physician care that includes an APP who is billing independently, at least for certain patients receiving chemotherapy, may be a viable strategy to safely leverage the scarce oncology workforce to increase access and delivery of cancer care.


Sign in / Sign up

Export Citation Format

Share Document